Related Experiment Videos
[Interferon alpha treatment in chronic hepatitis C]
Giornale Di Batteriologia, Virologia Ed Immunologia
|January 1, 1992
Summary
Alpha Interferon (IFN) effectively treated chronic hepatitis C in a 1990-1992 study. Better outcomes were seen in younger patients, drug addicts, and those with high transaminases.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Alpha Interferon (IFN) has shown efficacy in treating chronic hepatitis C.
- Optimal patient selection and therapy schedules for Alpha IFN remain subjects of debate.
Purpose of the Study:
- To evaluate the effectiveness and outcomes of Alpha Interferon treatment for chronic hepatitis C.
- To identify patient characteristics associated with a better treatment response.
Main Methods:
- A cohort of 36 chronic hepatitis C patients received Alpha IFN (1-6 MU thrice weekly for 6-12 months).
- Clinical response was assessed via serum transaminases.
- Follow-up averaged 8.5 months post-therapy.
Main Results:
- Full response: 9 patients; Relapse: 9 patients; Partial response: 6 patients; Treatment failure: 9 patients.
- Younger patients, drug addicts, those with chronic persistent hepatitis, and high transaminases showed better responses.
- Side effects were frequent but generally transient and rarely led to treatment discontinuation.
Conclusions:
- Alpha Interferon demonstrated variable efficacy in chronic hepatitis C treatment.
- Patient factors such as age, drug use history, hepatitis type, and baseline transaminase levels influenced treatment outcomes.
- Further research is needed to refine patient selection and therapeutic strategies for Alpha IFN in chronic hepatitis C.